Harte Hanks (HHS) Cost of Revenue (2019 - 2026)

Harte Hanks (HHS) has reported Cost of Revenue for 8 consecutive years, with $11.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue fell 19.34% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $47.2 million (down 17.16% YoY), while the FY2025 annual figure was $49.9 million, down 11.91% from the prior year.
• Cost of Revenue fell to $11.3 million in Q1 2026 per HHS's latest filing, from $11.7 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $19.5 million in Q4 2022 and bottomed at $11.3 million in Q1 2026.
• Historically, Cost of Revenue has averaged $14.1 million across 5 years, with a median of $13.8 million in 2024.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 154.44% — and 2025, when it decreased 20.8%.
• Harte Hanks' Cost of Revenue stood at $19.5 million in 2022, then declined by 15.98% to $16.4 million in 2023, then dropped by 9.85% to $14.8 million in 2024, then decreased by 20.8% to $11.7 million in 2025, then dropped by 3.23% to $11.3 million in 2026.
• Business Quant data shows HHS's Cost of Revenue at $11.3 million in Q1 2026, $11.7 million in Q4 2025, and $11.7 million in Q3 2025.